Omzet 2024 * | 2,72 mld. 10,29 mld. 2,54 mld. | Omzet 2025 * | 3,05 mld. 11,54 mld. 2,85 mld. | Marktkapitalisatie | 14,48 mld. 54,77 mld. 13,52 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 439 mln. 1,66 mld. 410 mln. | Nettowinst (verlies) 2025 * | 528 mln. 2 mld. 493 mln. | EV/omzet 2024 * | 4,84 x |
Nettoliquiditeiten 2024 * | 1,32 mld. 4,98 mld. 1,23 mld. | Nettoliquiditeiten 2025 * | 2,15 mld. 8,14 mld. 2,01 mld. | EV/omzet 2025 * | 4,04 x |
K/w-verhouding 2024 * |
35,1
x | K/w-verhouding 2025 * |
28,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,78% | 3.039 mld. | |
+2,45% | 80,47 mld. | |
+1,94% | 75,69 mld. | |
-13,26% | 54,73 mld. | |
-16,33% | 51,62 mld. | |
+25,74% | 47,77 mld. | |
+16,44% | 40,95 mld. | |
+56,22% | 35,86 mld. | |
-11,26% | 24,36 mld. |